Association of Sarcopenia and NAFLD: An Overview.
作者信息
Li Andrew A, Kim Donghee, Ahmed Aijaz
机构信息
Department of Medicine Stanford University School of Medicine Stanford CA.
Division of Gastroenterology and Hepatology Stanford University School of Medicine Stanford CA.
出版信息
Clin Liver Dis (Hoboken). 2020 Sep 4;16(2):73-76. doi: 10.1002/cld.900. eCollection 2020 Aug.
Abstract
摘要
相似文献
1
Association of Sarcopenia and NAFLD: An Overview.肌肉减少症与非酒精性脂肪性肝病的关联：综述
Clin Liver Dis (Hoboken). 2020 Sep 4;16(2):73-76. doi: 10.1002/cld.900. eCollection 2020 Aug.
2
Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity?非酒精性脂肪性肝病患者的肌肉减少症：它是一种具有临床意义的实体吗？
Obes Rev. 2019 Feb;20(2):353-363. doi: 10.1111/obr.12776. Epub 2018 Nov 25.
3
Sarcopenia and fatty liver disease.肌肉减少症与脂肪肝。
Hepatol Int. 2019 Nov;13(6):674-687. doi: 10.1007/s12072-019-09996-7. Epub 2019 Nov 8.
4
Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).肌肉减少症与非酒精性脂肪性肝病中肥胖和胰岛素抵抗无关，与显著的肝纤维化相关：全国性调查（KNHANES 2008-2011）。
Hepatology. 2016 Mar;63(3):776-86. doi: 10.1002/hep.28376. Epub 2016 Jan 14.
5
The Relationship between NAFLD and Sarcopenia in Elderly Patients.非酒精性脂肪性肝病与老年患者肌少症的关系。
Can J Gastroenterol Hepatol. 2018 Mar 26;2018:5016091. doi: 10.1155/2018/5016091. eCollection 2018.
6
Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.非酒精性脂肪性肝病在鹿特丹研究中的表现：肌肉质量、肌少症、脂肪质量和脂肪分布。
J Bone Miner Res. 2019 Jul;34(7):1254-1263. doi: 10.1002/jbmr.3713. Epub 2019 May 10.
7
The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass.非酒精性脂肪性肝病与CT测量的骨骼肌质量之间的关联
J Clin Med. 2018 Sep 28;7(10):310. doi: 10.3390/jcm7100310.
8
Sarcopenia Contributes to the Progression of Nonalcoholic Fatty Liver Disease- Related Fibrosis: A Meta-Analysis.肌肉减少症促进非酒精性脂肪性肝病相关纤维化的进展：一项荟萃分析。
Dig Dis. 2018;36(6):427-436. doi: 10.1159/000491015. Epub 2018 Jul 26.
9
The Common Mechanisms of Sarcopenia and NAFLD.肌肉减少症与非酒精性脂肪性肝病的共同发病机制。
Biomed Res Int. 2017;2017:6297651. doi: 10.1155/2017/6297651. Epub 2017 Dec 13.
10
Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.60 岁以上人群中的非酒精性脂肪性肝病：肌少症和肥胖的影响。
Maturitas. 2019 Jun;124:48-54. doi: 10.1016/j.maturitas.2019.03.016. Epub 2019 Mar 25.
引用本文的文献
1
Comparison of sarcopenia screening indices using serum creatinine and cystatin C in metabolic dysfunction-associated steatotic liver disease.使用血清肌酐和胱抑素C的肌肉减少症筛查指标在代谢功能障碍相关脂肪性肝病中的比较
Front Med (Lausanne). 2025 Aug 7;12:1633837. doi: 10.3389/fmed.2025.1633837. eCollection 2025.
2
Influence of pre-operative sarcopenia on post-operative hepatic steatosis after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.术前肌肉减少症对胰腺导管腺癌胰十二指肠切除术后肝脂肪变性的影响。
J Gastrointest Oncol. 2025 Jun 30;16(3):1305-1313. doi: 10.21037/jgo-24-700. Epub 2025 Jun 24.
3
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics.非酒精性脂肪性肝病中的肠道微生物群：病理生理学、诊断与治疗
World J Hepatol. 2025 Jun 27;17(6):106849. doi: 10.4254/wjh.v17.i6.106849.
4
Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia.解析代谢相关脂肪性肝病（MAFLD）与肌肉减少症之间的代谢途径
Int J Mol Sci. 2025 May 14;26(10):4673. doi: 10.3390/ijms26104673.
5
Association between muscular strength, abdominal obesity, and incident nonalcoholic fatty liver disease in a Korean population.韩国人群中肌肉力量、腹部肥胖与非酒精性脂肪性肝病发病之间的关联。
Sci Rep. 2025 May 21;15(1):17602. doi: 10.1038/s41598-025-00377-9.
6
Impact of Alcohol Intake on Body Composition in Patients with Steatotic Liver Disease.酒精摄入对脂肪性肝病患者身体成分的影响。
Nutrients. 2025 Mar 20;17(6):1092. doi: 10.3390/nu17061092.
7
Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.代谢功能障碍相关脂肪性肝病中骨骼肌改变及循环肌动蛋白的评估：一项横断面研究。
World J Gastroenterol. 2025 Feb 21;31(7):100039. doi: 10.3748/wjg.v31.i7.100039.
8
Relationship between Sarcopenia and minimal hepatic encephalopathy in patients with cirrhosis: a prospective observational study.肝硬化患者肌肉减少症与轻微肝性脑病之间的关系：一项前瞻性观察研究。
BMC Gastroenterol. 2025 Feb 17;25(1):88. doi: 10.1186/s12876-025-03674-9.
9
Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease.营养、饮食策略、运动、生活方式及环境对非酒精性脂肪性肝病的预防作用。
Ann Med. 2025 Dec;57(1):2464223. doi: 10.1080/07853890.2025.2464223. Epub 2025 Feb 12.
10
The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies.肠道微生物群修饰在非酒精性脂肪性肝病治疗策略中的作用
Int J Hepatol. 2024 Oct 16;2024:4183880. doi: 10.1155/2024/4183880. eCollection 2024.
本文引用的文献
1
Arresting frailty and sarcopenia in cirrhosis: Future prospects.阻止肝硬化中的衰弱和肌肉减少症：未来前景。
Clin Liver Dis (Hoboken). 2018 Feb 28;11(2):52-57. doi: 10.1002/cld.691. eCollection 2018 Feb.
2
Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.在美国，肌少症与非酒精性脂肪性肝病及其肝纤维化程度的相关性。
Eur J Gastroenterol Hepatol. 2019 Sep;31(9):1121-1128. doi: 10.1097/MEG.0000000000001397.
3
A framework to determine when liver transplantation is futile.一种确定肝移植何时无意义的框架。
Clin Liver Dis (Hoboken). 2016 Dec;8(6):137-139. doi: 10.1002/cld.589. Epub 2016 Dec 30.
4
Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.骨骼肌量与非酒精性脂肪性肝病的关系：一项 7 年纵向研究。
Hepatology. 2018 Nov;68(5):1755-1768. doi: 10.1002/hep.30049. Epub 2018 Oct 14.
5
Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.隐匿性肌肉减少症：低估非酒精性脂肪性肝炎肌肉功能障碍的风险和后果。
Hepatology. 2017 Dec;66(6):2055-2065. doi: 10.1002/hep.29420. Epub 2017 Oct 30.
6
The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist.移植之路漫漫：恶病质和衰弱如何影响等待名单上的发病率和死亡率。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1492-1497. doi: 10.1016/j.cgh.2017.04.004. Epub 2017 Apr 8.
7
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease.肌肉减少症与非酒精性脂肪性肝病患者的严重肝纤维化有关。
Aliment Pharmacol Ther. 2017 Feb;45(4):510-518. doi: 10.1111/apt.13889. Epub 2016 Dec 27.
8
Lean NAFLD: An Underrecognized Outlier.瘦型非酒精性脂肪性肝病：一种未被充分认识的异常情况。
Curr Hepatol Rep. 2016 Jun;15(2):134-139. doi: 10.1007/s11901-016-0302-1. Epub 2016 Apr 14.
9
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.肌肉减少症是非酒精性脂肪性肝炎和显著纤维化的独立危险因素。
J Hepatol. 2017 Jan;66(1):123-131. doi: 10.1016/j.jhep.2016.08.019. Epub 2016 Sep 4.
10
Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.肌肉减少性肥胖和肌脂肪变性与肝硬化患者较高的死亡率相关。
J Cachexia Sarcopenia Muscle. 2016 May;7(2):126-35. doi: 10.1002/jcsm.12039. Epub 2015 Jun 9.
Zotero 插件